Eric Goldberg

Eric Goldberg

Auto-generated profile, based on publicly available information

Eric Goldberg

Division of Gastroenterology, University of Maryland Medical Center, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
JSJason S. Shapiro
Jason S. Shapiro
JKJoseph Kannry
Joseph Kannry
MLMark Lipton
Mark Lipton
EGEric Goldberg
Eric Goldberg
PCPaul Conocenti
Paul Conocenti
GKGilad Kuperman
Gilad Kuperman

18 November 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DCDeborah Cragun
Deborah Cragun
KKKerstin Kalke
Kerstin Kalke
DCDaniel Chavez-Yenter
Daniel Chavez-Yenter
KKKadyn E Kimball
Kadyn E Kimball
WKWendy Kohlmann
Wendy Kohlmann
KKKimberly A. Kaphingst
Kimberly A. Kaphingst
Background: Cancer genetic testing to assess an individual’s cancer risk and to enable genomics-informed cancer treatment has grown exponentially in the past decade. Because of this continued growth and a shortage of health care workers, there is a need for automated strategies that provide high-quality genetics services to patients to reduce the clinical demand for genetics providers. Conversational agents have shown promise in managing mental health, pain, and other chronic conditions and are increasingly being used in cancer genetic services. However, research on how patients interact with these agents to satisfy their information needs is limited. Objective: Our primary aim is to assess user interactions with a conversational agent for pretest genetics education. Methods: We conducted a feasibility study of user interactions with a conversational agent who delivers pretest genetics education to primary care patients without cancer who are eligible for cancer genetic evaluation. The conversational agent provided scripted content similar to that delivered in a pretest genetic counseling visit for cancer genetic testing. Outside of a core set of information delivered to all patients, users were able to navigate within the chat to request additional content in their areas of interest. An artificial intelligence–based preprogrammed library was also established to allow users to ask open-ended questions to the conversational agent. Transcripts of the interactions were recorded. Here, we describe the information selected, time spent to complete the chat, and use of the open-ended question feature. Descriptive statistics were used for quantitative measures, and thematic analyses were used for qualitative responses. Results: We invited 103 patients to participate, of which 88.3% (91/103) were offered access to the conversational agent, 39% (36/91) started the chat, and 32% (30/91) completed the chat. Most users who completed the chat indicated that they wanted to continue with genetic testing (21/30, 70%), few were unsure (9/30, 30%), and no patient declined to move forward with testing. Those who decided to test spent an average of 10 (SD 2.57) minutes on the chat, selected an average of 1.87 (SD 1.2) additional pieces of information, and generally did not ask open-ended questions. Those who were unsure spent 4 more minutes on average (mean 14.1, SD 7.41; P=.03) on the chat, selected an average of 3.67 (SD 2.9) additional pieces of information, and asked at least one open-ended question. Conclusions: The pretest chat provided enough information for most patients to decide on cancer genetic testing, as indicated by the small number of open-ended questions. A subset of participants were still unsure about receiving genetic testing and may require additional education or interpersonal support before making a testing decision. Conversational agents have the potential to become a scalable alternative for pretest genetics education, reducing the clinical demand on genetics providers.

10 September 2020 in Medicina
Verified
Journal Article
Open access
PDF file
ARAllison B Reiss
Allison B Reiss
JLJoshua De Leon
Joshua De Leon
IDIsaac Dapkins
Isaac Dapkins
GSGeorge Shahin
George Shahin
MPMorgan Peltier
Morgan Peltier
EGEric R. Goldberg
Eric R. Goldberg
Covid-19 is a new highly contagious RNA viral disease that has caused a global pandemic. Human-to-human transmission occurs primarily through oral and nasal droplets and possibly through the airborne route. The disease may be asymptomatic or the course may be mild with upper respiratory symptoms, moderate with non-life-threatening pneumonia, or severe with pneumonia and acute respiratory distress syndrome. The severe form is associated with significant morbidity and mortality. While patients who are unstable and in acute distress need immediate in-person attention, many patients can be evaluated at home by telemedicine or videoconferencing. The more benign manifestations of Covid-19 may be managed from home to maintain quarantine, thus avoiding spread to other patients and health care workers. This document provides an overview of the clinical presentation of Covid-19, emphasizing telemedicine strategies for assessment and triage of patients. Advantages of the virtual visit during this time of social distancing are highlighted.

28 June 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
ANArielle R Nagler
Arielle R Nagler
EGEric R Goldberg
Eric R Goldberg
MAMaria E Aguero-Rosenfeld
Maria E Aguero-Rosenfeld
JCJoan Cangiarella
Joan Cangiarella
GKGary Kalkut
Gary Kalkut
RCRobert J Cerfolio
Robert J Cerfolio
Coronavirus disease 2019 (COVID-19) reverse-transcription polymerase chain reaction employee testing was implemented across New York University Langone Health. Over 8 weeks, 14 764 employees were tested; 33% of symptomatic employees, 8% of asymptomatic employees reporting COVID-19 exposure, and 3% of employees returning to work were positive. Positivity rates declined over time, possibly reflecting the importance of community transmission and efficacy of personal protective equipment.

2 May 2023 in The American Surgeon™
Verified
Journal Article
Closed access
ZLZachariah L. Lee
Zachariah L. Lee
LCLaura Cooper
Laura Cooper
EGEric Goldberg
Eric Goldberg
BCBryan Curtin
Bryan Curtin
RBRebecca F. Brown
Rebecca F. Brown

1 March 2008 in Kidney International
Verified
Journal Article
Open access
PDF file
KKK. Kiryluk
K. Kiryluk
RRR.A. Rabenou
R.A. Rabenou
EGE.R. Goldberg
E.R. Goldberg
MGM. Gupta
M. Gupta
A 31-year-old woman presented with headaches and high blood pressure (180/100 mm Hg). She had a history of four kidney infections in the last 10 years. There was no family history of kidney disease. Her physical exam was unremarkable, the creatinine was 1.0 mg per 100 ml (Ref. 0.5–0.9), blood urea nitrogen 17 mg per 100 ml (Ref. 7–20), and urinalysis was normal. Renal ultrasonography revealed three large cysts in the right kidney (2.8 cm upper pole, 4.4 cm mid portion, and 2.4 cm lower pole) and two cysts in the left kidney (4.1 and 1.9 cm, both at the upper pole). Doppler evaluation was negative for renal artery stenoses. Magnetic resonance imaging was performed (Figures 1 Figures 1 and 2 2 ).